SS1. Impact of Transfusion and Nadir Postoperative Hemoglobin on Short- and Long-term Outcomes after Interventions for Peripheral Arterial Disease (PAD)  by Kougias, Panos et al.
Results: There were 23 consultations performed for
hand ischemia related to radial artery catheters. Compared to
nonischemic controls consulted patients were more likely to
have shock (P.002), sepsis (P.01), and be receiving anti-
coagulation (P.04). Twelve patients (52%) required surgical
revascularization; thrombectomy (91.7%), intraoperative
thrombolysis (58.3%), vein patch angioplasty (33.3%), and
intraoperative angiography (50%). In patientswhounderwent
revascularization, 2 required digital amputation, 1 required
major upper extremity amputation, and 2 patients died. In
patients who underwent nonoperative management, none
required amputation. Overall mortality was 22% in patients
requiring vascular consultation and 17% in those requiring
operation for radial artery catheter ischemic complications.
Conclusions: Fifty-two percent of patients with isch-
emic complications of radial artery catheters require oper-
ation and mortality is high. Patients with shock and sepsis
are more likely to develop radial catheter-associated upper
extremity ischemia. Those requiring revascularization have
a high rate of digital or major upper extremity amputation.
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Objectives: Controversy surrounds the topic of trans-
fusion policy after non-cardiac operations. This study as-
sessed the combined impact of postoperative nadir hemo-
globin (nHb) levels and blood transfusion on adverse
events after open surgical intervention in patients with
PAD.
Methods: Consecutive patients (n1182) who under-
went PAD-related operations were matched on propensity
scores calculated as their probability to have nHb more or
less than 10gm/dl on the basis of operation type, demo-
graphics and comorbidities, including the revised cardiac
risk index. Logistic and Cox proportional hazards regres-
sions were used to assess the impact of nHb and number of
transfused units on 1) a composite endpoint (CE) of death,
myocardial infarction and stroke; 2) respiratory and wound
complications.
Results: After adjusting for nHb level, the number of
units transfused was a strong predictor for the perioperative
occurrence of the CE (OR,1.12, P.02) and respiratory
complications (OR, 1.27, P.004). Adjusted for the num-
ber of units transfused, nHb had no impact on the periop-
erative CE (OR, 0.6, P.3) or respiratory events (OR,
0.40, P.17). An interaction term between transfusion and
nHb level remain non-significant (P.543), indicating that
the impact of blood transfusion was the same regardless of
nHb level. Perioperative wound infections were less com-
mon in patients with nHb 10gm/dl (OR, 0.59, P.04),
whereas transfusion had no impact on wound infection
rates (OR, 0.98, P.84). During an average follow up of
24 months transfused patients were more likely to develop
the CE (HR, 1.13, P.02), whereas nHb level did not
impact the long term adverse event rate (HR, 0.7, P.26).
Conclusions: Blood transfusion increases the inci-
dence of perioperative and long-term mortality and cardio-
vascular adverse events regardless of the associated nHb. It
also increases the risk of perioperative respiratory compli-
cations. A restrictive transfusion strategy is justified in pa-
tients with PAD.
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Objectives: To evaluate the impact of pedal arch qual-
ity on the amputation-free survival and patency rates of
distal bypass grafts and also its direct impact on rate of
healing and time-to-healing of tissue loss following direct
angiosome revascularization in patients with critical limb
ischemia (CLI).
Methods:Between 2004 and 2011, patients undergoing
distal bypass for CLI (Rutherford 4-6) were divided in groups
taking in consideration the state of the pedal arch and direct
angiosome revascularization (DAR) and non-DAR. Based on
angiography, the pedal arch was divided into 3 groups; com-
plete pedal arch (CPA), incomplete pedal arch (IPA) and no
pedal arch (NPA). Kaplan-Meier was used to analyse patency
rates at 12months, amputation-free survival at 48months, the
rate of healing and time-to-healing of tissue loss.
Results: Total of 167 bypasses was included in the
analysis. 31(19%) had CPA, 104 (62%) IPA and 32 (19%)
had NPA. Incidence of diabetes mellitus and chronic renal
failure was similar in all groups. The primary and secondary
patency rates at 1-year as well as the amputation-free sur-
vival at 48 months for all groups were: CPA, 58.4%, 86.0%
and 67.2% (P.5168); IPA, 54.6%, 84.7% and 69.7%
(P.8940); and NPA, 63.8%, 88.8% and 45.9%
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